Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)
QNTM
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.49M
Close$
$0.01
99.7% downside
Current Fair Value
99.7% downsideOvervalued by 99.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $18.49 Million |
|---|---|
| Enterprise Value | $15.01 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.11 |
| Beta | 0.44 |
| Outstanding Shares | 4,489,456 |
Return
| Return on Equity | -5193.98% |
|---|---|
| Return on Assets | -207.13% |
| Return on Invested Capital | 1364.52% |
Valuation & Multiples
| P/E Ratio | -0.35 |
|---|---|
| PEG | -0.62 |
| Price to Sales | - |
| Price to Book Ratio | -3.05 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.77 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 1.46 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-0.89
Average shareholder expectationRevenue Estimate
$3.74 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.66%▲ 2.36% |
|---|---|
| Total Invested | $1.23M▲ 31.01% |
| Investors Holding | 24▲ 1.00% |
ESG Score
No data
About Quantum BioPharma Ltd.
5 employees
CEO: Raza Bokhari fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based...